JP3790591B2 - Functional material with visible effect end point - Google Patents
Functional material with visible effect end point Download PDFInfo
- Publication number
- JP3790591B2 JP3790591B2 JP31785396A JP31785396A JP3790591B2 JP 3790591 B2 JP3790591 B2 JP 3790591B2 JP 31785396 A JP31785396 A JP 31785396A JP 31785396 A JP31785396 A JP 31785396A JP 3790591 B2 JP3790591 B2 JP 3790591B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- wax
- functional material
- carrier
- end point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Description
【0001】
【発明の属する技術分野】
この発明は、芳香剤、消臭剤、抗菌剤、防カビ剤、防虫剤など揮散性薬剤を使用した機能材、特に効果の終了時点を目視によって確認することが可能な機能材に関するものである。
【0002】
【従来の技術】
従来、芳香剤等の揮散性薬剤に、揮散性の染料を混合し、揮散性薬剤と共に、染料を同時に揮散させて、色彩の減色によって、薬剤の減少、即ち、薬効を視覚的に確認できるようにしたものがある。
【0003】
【発明が解決しようとする課題】
ところが、上記のものは、揮散性薬剤の揮散と染料の揮散とが時間的に必ずしも一致しないので、揮散性薬剤が残存しているのに、染料が先に揮散してしまうと、薬効も終了したと判断せざるを得ず、薬剤が無駄になったり、反対に揮散性薬剤が全部揮散してしまっているのに、染料が残っていると、薬効のないものをそのまま使用してしまうという問題があった。
【0004】
一方、揮散性薬剤の揮散に伴い、呈色性有機化合物自体が化学変化を生じることによる変色によって薬効を視覚的に確認しようとするものがある。この場合、上記のような薬効終了時点と変色との時差は生じないが、揮散性薬剤と呈色性有機化合物との組合せが重要であり、使用できる揮散性薬剤が限定されるという欠点がある。また、使用可能なものでも薬剤の揮散に伴い、呈色性有機化合物の色彩を帯びてくるものがほとんどであるので、薬効終了というイメージと結びつかないという欠点もある。
【0005】
そこで、この発明は、揮散性薬剤の揮散と色調の変化を直接関連付けることにより、薬効の終了時期を確実に目視によって確認することができると共に、油溶性染料を溶解することができる揮散性薬剤が例外なく使用可能で、色彩の減色によって薬剤の減少を視覚的に確認することができる機能材を提供しようとするものである。
【0006】
【課題を解決するための手段】
この発明は、油溶性染料と界面活性剤とを溶解させた揮散性薬剤を、セルロースビーズ等の親水性素材やワックス等、油溶性染料に対して非染色性、すなわち、なじみの悪い担体に担持せしめて機能材としたものである。
【0007】
上記担体に担持させられた油溶性染料は、揮散性薬剤が存在している場合には、薬液中に溶解している。このため、担体表面が、染料が溶解した薬液によって覆われるので、担体が色彩を呈する(図1の概念図)。
【0008】
そして、揮散性薬剤が揮散して、薬剤中の油溶性染料の濃度が高くなると、界面活性剤が凝集剤として機能し、油溶性物質に対してなじみの悪い担体表面で、油溶性染料が局所的に凝集析出して大きな固まりとなる。これにより、凝集析出した染料の固まりは、固まりの一部が担体の表面から顔を出すだけになるので、染料の色彩は目立たず、全体としては担体自体の色彩を呈する(図2の概念図参照)。
【0009】
したがって、この色調の変化により、揮散性薬剤の揮散状態、すなわち、薬効の有無を確認することが可能となる。
【0010】
なお、図1、図2において、符号1は担体、2は染料を示している。
【0011】
この発明で使用する揮散性薬剤としては、後述の油溶性染料を溶解させる親油性のものであり、芳香剤として使用されるリモネン、リナロール、シトラール、カルボン、アントラニル酸メチル、抗菌・防カビ剤として使用されるアリルイソチオシアネート、オクチルアルデヒド、オイゲノール、ブロムシンナミルアルデヒド、精油・消臭剤として使用されるヒバ油、ヒノキ油、ユーカリ油、防虫剤として使用されるピレスロイド、ハッカ油、その他忌避剤、フェロモン等がある。
【0012】
油溶性染料としては、分散染料、例えば、C.I.Disp. Yellow 64、C.I.Disp. Yellow 54、 C.I.Disp. Red60、C.I.Disp. Blue 60、C.I.Disp. Blue 56、C.I.Disp. Blue 334、油溶染料、例えば、C.I.Solvent Yellow 33、C.I.Solvent Red52、C.I.Solvent Blue 11、建染染料、例えば、C.I.Vat Yellow 1、 C.I.Vat Red1、C.I.Vat Blue 1、硫化染料、例えば、C.I.Sulphur Yellow 1、C.I.Sulphur Red3、C.I.SulphurBlue 1、媒染染料、例えば、C.I.Mordant Yellow 3、C.I.Mordant Red11、C.I.Mordant Blue 1、アゾイック染料、例えば、C.I.Azoic Yellow 2、C.I.Azoic Red2、C.I.Azoic Blue 6、等がある。
【0013】
界面活性剤としては、陰イオン界面活性剤、例えば、スルホン酸塩、硫酸エステル塩、陽イオン界面活性剤、例えば、脂肪族4級アンモニウム塩、ベンザルコニウム塩、両性界面活性剤、例えば、カルボキシベタイン型、非イオン界面活性剤、例えば、ポリエチレングリコールアルキルフェニルエーテル等があり、特に、陰イオン界面活性剤が良好である。
【0014】
界面活性剤を使用しない場合、揮散性薬剤が揮散して薬剤中の油溶性染料の濃度が高くなっても、油溶性染料が凝集析出しにくく、界面活性剤が存在する場合のように、大きな固まりは形成されずに、担体表面全体に染料が膜状に析出するため、色彩変化を判別しにくい。界面活性剤の使用量としては、油溶性染料に対し、10〜300重量%が好ましい。10重量%未満では界面活性剤の効果が得にくい場合があり、300重量%を超えると、薬剤が揮散しきらないうちに凝集析出を起こしてしまい、薬効が終了したものと勘違いする場合があるからである。
【0015】
次に、油溶性染料を界面活性剤と共に溶解させた揮散性薬剤を担持させる担体としては、油溶性染料に対して非染色性、即ち、なじみの悪いもの、例えば、セルロースビーズ、セルローススポンジ、及び紙等のセルロース多孔質体、又は、親水性繊維で形成された織布、不織布、又は、ケイ酸カルシウム、アルミナ、シリカゲル、ゼオライト等の親水性多孔質素材、又は、鉱物ワックス(オゾケライト)、石油ワックス(パラフィンワックス、マイクロクリスタリンワックス)、天然ワックス(脂肪酸、カルナバワックス、ライスワックス)等のワックスを使用する。これは、担体として、油溶性染料に対してなじみの良いものを使用した場合、担体自体が油溶性染料によって染色されて、揮散性薬剤が揮散しても、染料が凝集せず、色彩が変化しないからと考えられる。また、上記ワックス類を溶融し、これに揮散性薬剤、油溶性染料、界面活性剤を混練し、この混練液を上記親水性多孔質素材の孔部に包埋すると、薬効の目視確認に加え、徐放性も具備できるのでより好ましい。
【0016】
【実施例】
この発明の実施例と比較例として、以下の実験を行い、その結果を表1に示す。
【0017】
〔実施例1〕
親油性の揮散性薬剤であるアリルイソチオシアネート(以下、「AIT」という、関東化学(株)社製)10gに、油溶性染料であるC.I.Disp. Blue 60を2mg、界面活性剤であるナフタリンスルホン酸塩ホルマリン縮合物3mgを溶解させた液体を、セルロースビーズ(レンゴー(株)社製 ビスコパール)5gに含浸させた。この含浸ビーズを室温に放置してAITを完全に揮散させた。また、色調は、作製時とAITが完全に揮散した時のビーズの色を目視で判断した。なお、揮散後、AIT10gに上記ビーズを含浸すると白色になったビーズが再び青色に戻った。
【0018】
〔実施例2〕
油溶性染料をC.I.Disp. Red60に代えた以外は、実施例1と同じである。
【0019】
〔実施例3〕
揮散性薬剤を、リモネン(ナカライテスク(株)社製)に代えた以外は、実施例1と同じである。
【0020】
〔実施例4〕
担体を、ケイ酸カルシウム(徳山曹達(株)社製 フローライトRM40)に代えた以外は、実施例1と同じである。
【0021】
〔実施例5〕
AIT10gとC.I.Disp. Blue 60を2mgとナフタリンスルホン酸塩ホルマリン縮合物を3mgとパラフィンワックス(日本精蝋(株)社製)5gを加熱溶融して混練した液体を、セルロースビーズ6gに含浸させた。AITの色調の判断は、実施例1と同じである。
【0022】
〔実施例6〕
油溶性染料をC.I.Azoic Red2に代えた以外は実施例1と同じである。
【0023】
〔実施例7〕
界面活性剤をポリオキシエチレンソルビタンモノオレエート(ナカライテスク(株)社製)に代えた以外は実施例1と同じである。
【0024】
〔比較例1〕
C.I.Disp. Blue 60を、顔料のPigment R.146に代えた以外は、実施例1と同じである。
【0025】
〔比較例2〕
C.I.Disp. Blue 60を、水溶性染料のAcid Blue112に代え、揮散性薬剤をエタノールに代えた以外は、実施例1と同じである。
【0026】
〔比較例3〕
ナフタリンスルホン酸塩ホルマリン縮合物3mgを添加しない以外は、実施例1と同じである。
【0027】
〔比較例4〕
ナフタリンスルホン酸塩ホルマリン縮合物3mgを添加しない以外は実施例6と同じである。
【0028】
〔比較例5〕
担体を、油溶性染料に対し染色性の発泡ポリウレタンに代えた以外は実施例1と同じである。
【0029】
【表1】
【0030】
【発明の効果】
この発明によれば、以上のように、揮散性薬剤の揮散に直接関連して色調が変化する、具体的には減色する、即ち、薬効の終了時期を確実に目視によって確認することができ、また、油溶性染料を溶解する揮散性薬剤が例外なく使用可能であり、さらに、薬効終了後、揮散性薬剤を添加することにより再利用も可能な機能材を得ることができる。
【図面の簡単な説明】
【図1】揮散性薬剤の薬液中に染料が溶解して担体表面を覆っている状態を示したこの発明の概念図
【図2】揮散性薬剤が揮散して担体表面に染料が局所的に凝集析出して担体表面が露出する状態を示したこの発明の機能材の概念図
【符号の説明】
1 担体
2 染料[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a functional material using a volatile agent such as a fragrance, a deodorant, an antibacterial agent, an antifungal agent, and an insect repellent, and particularly to a functional material capable of visually confirming the end point of the effect. .
[0002]
[Prior art]
Conventionally, volatilizing dyes such as fragrances are mixed with volatile dyes, and together with the volatile chemicals, the dyes are volatilized at the same time. There is something that was made.
[0003]
[Problems to be solved by the invention]
However, since the volatilization agent volatilization and the dye volatilization do not necessarily coincide with each other in time, the medicinal effect ends when the volatilization agent remains but the dye volatilizes first. It is necessary to judge that the drug has been wasted, or on the contrary, all the volatile chemicals have been volatilized, but if the dye remains, it will be used as it is without medicinal properties There was a problem.
[0004]
On the other hand, with the volatilization of volatilizing chemicals, there is one that attempts to visually confirm the medicinal effect by color change caused by a chemical change of the colored organic compound itself. In this case, there is no time difference between the end point of the effect and the discoloration as described above, but the combination of the volatile drug and the colorable organic compound is important, and there is a disadvantage that the volatile drug that can be used is limited. . In addition, even those that can be used have the color of the color-forming organic compound due to the volatilization of the drug, so there is a disadvantage that it is not linked to the image of the end of the medicinal effect.
[0005]
Therefore, the present invention relates directly to the volatilization of the volatilizing agent and the change in color tone, thereby making it possible to reliably confirm the end time of the medicinal effect by visual observation and to provide a volatilizing agent capable of dissolving the oil-soluble dye. It is an object of the present invention to provide a functional material that can be used without exception and that can visually confirm the decrease of the drug by color reduction.
[0006]
[Means for Solving the Problems]
The present invention carries a volatilizing agent in which an oil-soluble dye and a surfactant are dissolved on a non-staining, that is, unfamiliar carrier with an oil-soluble dye, such as a hydrophilic material such as cellulose beads or wax. At least it is a functional material.
[0007]
The oil-soluble dye supported on the carrier is dissolved in the chemical solution when a volatile chemical is present. For this reason, since the carrier surface is covered with the chemical solution in which the dye is dissolved, the carrier exhibits a color (conceptual diagram of FIG. 1).
[0008]
When the volatilizing agent is volatilized and the concentration of the oil-soluble dye in the agent becomes high, the surfactant functions as an aggregating agent, and the oil-soluble dye is locally applied on the surface of the carrier that is not familiar to the oil-soluble substance. Thus, it aggregates and precipitates to form a large mass. As a result, the agglomerated and precipitated dye mass is only partially exposed from the surface of the carrier, so the color of the dye is not conspicuous, and the color of the carrier itself is exhibited as a whole (conceptual diagram of FIG. 2). reference).
[0009]
Therefore, it becomes possible to confirm the volatilization state of the volatile drug, that is, the presence or absence of the medicinal effect, by this change in color tone.
[0010]
In FIGS. 1 and 2,
[0011]
The volatile chemicals used in this invention are lipophilic to dissolve the oil-soluble dyes described later, and as limonene, linalool, citral, carvone, methyl anthranilate, antibacterial and antifungal agents used as fragrances Allyl isothiocyanate, octyl aldehyde, eugenol, bromcinnamyl aldehyde, Hiba oil, cypress oil, eucalyptus oil used as essential oil and deodorant, pyrethroid, mint oil used as insect repellent, other repellents, There are pheromones.
[0012]
Examples of oil-soluble dyes include disperse dyes such as C.I. I. Disp. Yellow 64, C.I. I. Disp. Yellow 54, C.I. I. Disp. Red 60, C.I. I. Disp. Blue 60, C.I. I. Disp. Blue 56, C.I. I. Disp. Blue 334, oil-soluble dyes such as C.I. I. Solvent Yellow 33, C.I. I. Solvent Red 52, C.I. I. Solvent Blue 11, vat dyes such as C.I. I. Vat Yellow 1, C.I. I. Vat Red1, C.I. I. Vat Blue 1, sulfur dyes such as C.I. I. Sulphur Yellow 1, C.I. I. Sulphur Red3, C.I. I. SulphurBlue 1, a mordant dye such as C.I. I. Mordant Yellow 3, C.I. I. Mordant Red11, C.I. I. Mordant Blue 1, an azoic dye such as C.I. I. Azoic Yellow 2, C.I. I. Azoic Red2, C.I. I. Azoic Blue 6, etc.
[0013]
Surfactants include anionic surfactants such as sulfonates, sulfate esters, cationic surfactants such as aliphatic quaternary ammonium salts, benzalkonium salts, amphoteric surfactants such as carboxy There are betaine type, nonionic surfactants such as polyethylene glycol alkylphenyl ether, and anionic surfactants are particularly good.
[0014]
When the surfactant is not used, even if the volatilizing agent is volatilized and the concentration of the oil-soluble dye in the agent is high, the oil-soluble dye is less likely to agglomerate and precipitate. The dye is deposited in the form of a film on the entire surface of the carrier without forming a lump, so that it is difficult to distinguish the color change. The amount of the surfactant used is preferably 10 to 300% by weight based on the oil-soluble dye. If the amount is less than 10% by weight, the effect of the surfactant may be difficult to obtain. If the amount exceeds 300% by weight, it may be misunderstood as a result of aggregation and precipitation before the chemical has completely volatilized, and the medicinal effect has ended. Because.
[0015]
Next, as a carrier for supporting a volatile drug in which an oil-soluble dye is dissolved together with a surfactant, non-staining, that is, unfamiliar to oil-soluble dyes, for example, cellulose beads, cellulose sponge, and Cellulose porous materials such as paper, woven fabrics, nonwoven fabrics, hydrophilic porous materials such as calcium silicate, alumina, silica gel, zeolite, etc., or mineral wax (ozokerite), petroleum Waxes such as wax (paraffin wax, microcrystalline wax) and natural wax (fatty acid, carnauba wax, rice wax) are used. This means that when a carrier that is familiar to oil-soluble dyes is used, even if the carrier itself is dyed with oil-soluble dyes and the volatile chemicals are volatilized, the dyes do not aggregate and the color changes. It is thought that it does not. In addition, when the waxes are melted and volatile chemicals, oil-soluble dyes, and surfactants are kneaded, and the kneaded liquid is embedded in the pores of the hydrophilic porous material, the medicinal effect is visually confirmed. Further, it is more preferable because it can have sustained release properties.
[0016]
【Example】
The following experiments were conducted as examples and comparative examples of the present invention, and the results are shown in Table 1.
[0017]
[Example 1]
An oil-soluble dye, C.I. I. A liquid in which 2 mg of Disp. Blue 60 and 3 mg of naphthalenesulfonate formalin condensate as a surfactant were dissolved was impregnated in 5 g of cellulose beads (Visco Pearl manufactured by Rengo Co., Ltd.). The impregnated beads were left at room temperature to completely volatilize AIT. Moreover, the color tone judged visually the color of the bead at the time of preparation and when AIT completely volatilized. After volatilization, when the beads were impregnated into 10 g of AIT, the white beads turned blue again.
[0018]
[Example 2]
The oil-soluble dye is C.I. I. The same as Example 1 except that it was replaced with Disp.
[0019]
Example 3
The same as Example 1 except that the volatile chemical was replaced with limonene (manufactured by Nacalai Tesque).
[0020]
Example 4
The same as Example 1, except that the carrier was replaced with calcium silicate (Florite RM40, manufactured by Tokuyama Soda Co., Ltd.).
[0021]
Example 5
AIT 10 g and C.I. I. 6 g of cellulose beads were impregnated with 2 g of Disp. Blue 60, 3 mg of naphthalene sulfonate formalin condensate and 5 g of paraffin wax (manufactured by Nippon Seiwa Co., Ltd.). The determination of the color tone of AIT is the same as in the first embodiment.
[0022]
Example 6
The oil-soluble dye is C.I. I. The same as Example 1 except that Azoic Red2 was used.
[0023]
Example 7
The same as Example 1 except that the surfactant was changed to polyoxyethylene sorbitan monooleate (manufactured by Nacalai Tesque).
[0024]
[Comparative Example 1]
C. I. Disp. Blue 60 is a pigment pigment. Example 1 is the same as Example 1 except that 146 is used.
[0025]
[Comparative Example 2]
C. I. Disp. Blue 60 is the same as Example 1 except that the water-soluble dye Acid Blue 112 is used and the volatilizing agent is replaced with ethanol.
[0026]
[Comparative Example 3]
Same as Example 1 except that 3 mg of naphthalene sulfonate formalin condensate is not added.
[0027]
[Comparative Example 4]
Same as Example 6 except that 3 mg of naphthalene sulfonate formalin condensate is not added.
[0028]
[Comparative Example 5]
Example 1 is the same as Example 1 except that the carrier is replaced with foamed polyurethane that is dyeable with respect to the oil-soluble dye.
[0029]
[Table 1]
[0030]
【The invention's effect】
According to this invention, as described above, the color tone changes directly in relation to the volatilization of the volatile drug, specifically, the color is reduced, that is, the end time of the medicinal effect can be surely confirmed visually. Moreover, the volatile chemical | medical agent which melt | dissolves an oil-soluble dye can be used without exception, Furthermore, the functional material which can be reused can be obtained by adding a volatile chemical | medical agent after completion | finish of a medicinal effect.
[Brief description of the drawings]
FIG. 1 is a conceptual diagram of the present invention showing a state in which a dye is dissolved in a chemical solution of a volatile drug and covers the carrier surface. FIG. 2 is a schematic diagram of the present invention. Conceptual diagram of the functional material of the present invention showing the state where the carrier surface is exposed by aggregation and precipitation [Explanation of symbols]
1
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31785396A JP3790591B2 (en) | 1996-11-28 | 1996-11-28 | Functional material with visible effect end point |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31785396A JP3790591B2 (en) | 1996-11-28 | 1996-11-28 | Functional material with visible effect end point |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10158628A JPH10158628A (en) | 1998-06-16 |
JP3790591B2 true JP3790591B2 (en) | 2006-06-28 |
Family
ID=18092795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP31785396A Expired - Fee Related JP3790591B2 (en) | 1996-11-28 | 1996-11-28 | Functional material with visible effect end point |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3790591B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124219A (en) * | 1997-08-29 | 2000-09-26 | Rengo Co., Ltd. | Functional material containing volatile agent |
JP4255316B2 (en) * | 2003-05-26 | 2009-04-15 | レンゴー株式会社 | Functional carrier and functional material using the same |
GB2416695A (en) * | 2004-08-07 | 2006-02-08 | Reckitt Benckiser | Air freshening, deodorising, pesticidal or insect repellent product |
GB2417203A (en) * | 2004-08-19 | 2006-02-22 | Reckitt Benckiser | Air freshening, deodorising, pesticidal or insect repellent product |
CN108184826B (en) * | 2017-12-28 | 2021-01-08 | 广州立白企业集团有限公司 | Color-changing mosquito-repelling hydrogel and preparation method thereof |
-
1996
- 1996-11-28 JP JP31785396A patent/JP3790591B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10158628A (en) | 1998-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU774993B2 (en) | Use-dependent indicator system for absorbent articles | |
US5093182A (en) | Sustained-release, print-compatible coatings for fragrance samplers | |
US5324445A (en) | Polymeric compositions | |
US5492646A (en) | Polymeric matrix particle compositions containing coacervate polymer shell | |
US6124219A (en) | Functional material containing volatile agent | |
JP3790591B2 (en) | Functional material with visible effect end point | |
CN103210056A (en) | Color-changing composition | |
US6312760B1 (en) | Surface coatings | |
JPH0693570A (en) | Method for sticking perfume and perfume-releasing fiber product | |
US8034325B2 (en) | Powder formed of particles of biliquid foam entrapped within polymeric matrix | |
JP4030182B2 (en) | A functional material that allows the end of volatilization of volatile chemicals to be visible | |
JPH06104922B2 (en) | Insect repellent stockings | |
JP4107698B2 (en) | A functional material that allows the end of volatilization of volatile chemicals to be visible | |
JPS63101301A (en) | Packaged drug | |
JPS62179640A (en) | Indication for end of efficacy of chemical | |
JPH1017846A (en) | Sustained-release functional agent | |
JPH07324003A (en) | Indicator for insecticide | |
JPH06116544A (en) | Display material and method for display | |
KR20040069831A (en) | Preparation Method for Microcapsule Insecticides | |
JP2003033428A (en) | Functional material | |
US6894001B2 (en) | Functional material containing volatile agent | |
KR20010110244A (en) | Manifactoring method for microcapsule including perfume of non-watersoluble | |
JP4298327B2 (en) | Functional materials | |
JPH04108728A (en) | Microcapsule and fibrous structure | |
JPH02290592A (en) | Time indicator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051213 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060210 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060314 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060403 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090407 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |